Towards Healthcare Research & Consulting
Latent Tuberculosis Infection Detection Market
Updated Date: 16 July 2026   |   Report Code: 6770
[email protected] +1 804-441-9344
Download Sample Order Now

Latent Tuberculosis Infection Detection Market Size, Growth and Forecast 2035

According to Shivani Zoting, who specializes in screening of high-risk populations, including healthcare workers and close contacts, public health surveillance and tuberculosis control programs, and advanced molecular and immunological diagnostic technologies with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the latent tuberculosis infection detection market. The global latent tuberculosis infection detection market size was estimated at USD 2.05 billion in 2025 and is predicted to increase from USD 2.17 billion in 2026 to approximately USD 3.65 billion by 2035, expanding at a CAGR of 5.94% from 2026 to 2035. Her analysis highlights the increasing adoption of interferon-gamma release assays for accurate LTBI diagnosis, advanced blood-based tuberculosis screening tests, molecular diagnostic technologies for early infection detection, and automated laboratory testing platforms. The research also examines the competitive strategies of key industry participants, including Qiagen, BD (Becton, Dickinson and Company), Thermo Fisher Scientific, Oxford Immunotec, Hologic, and Roche Diagnostics, shaping the future by expanding rapid and highly sensitive blood-based screening methods, integrating molecular diagnostics with automated laboratory platforms, improving access to point-of-care diagnostic solution in underserved region, and supporting precision pubic health through digital disease surveillance and data integration in the global latent tuberculosis infection detection market.

Last Updated : 16 July 2026 Category: Diagnostics Insight Code: 6770 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • Global Latent Tuberculosis Infection Detection Market Analysis, By Brand
    • Market Size, Forecast & CAGR, By Brand, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Latent Tuberculosis Infection Detection Market Analysis, By Test
    • Market Size, Forecast & CAGR, By Brand, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Latent Tuberculosis Infection Detection Market Analysis, By Application
    • Market Size, Forecast & CAGR, By Brand, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Latent Tuberculosis Infection Detection Market Analysis, By End Use
    • Market Size, Forecast & CAGR, By Brand, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Latent Tuberculosis Infection Detection Market Analysis, By Region
    • Market Size, Forecast & CAGR, By Brand, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Latent Tuberculosis Infection Detection Market Analysis
  • North America Latent Tuberculosis Infection Detection Market Analysis, By Brand, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Latent Tuberculosis Infection Detection Market Analysis, By Test, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Latent Tuberculosis Infection Detection Market Analysis, By Application, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Latent Tuberculosis Infection Detection Market Analysis, By End Use, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Latent Tuberculosis Infection Detection Market Analysis, By Country, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
      • U. S. Latent Tuberculosis Infection Detection Market Analysis
    • U. S. Latent Tuberculosis Infection Detection Market Analysis, By Brand, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U. S. Latent Tuberculosis Infection Detection Market Analysis, By Test, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U. S. Latent Tuberculosis Infection Detection Market Analysis, By Application, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U. S. Latent Tuberculosis Infection Detection Market Analysis, By End Use, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Similar Analysis will be given for each country and each region

  • Canada
  • Mexico
  • Rest of North America

Europe

  • Western Europe
  • Germany
  • Italy
  • France
  • Spain
  • UK
  • Netherlands
  • Switzerland
  • Nordic Countries
  • Rest of Western Europe
  • Eastern Europe
  • Austria
  • Russia & Belarus
  • Poland
  • Türkiye
  • Rest of Eastern Europe

Asia Pacific

  • China
  • Taiwan
  • India
  • Japan
  • Vietnam
  • Australia and New Zealand
  • ASEAN Countries
  • South Korea
  • Rest of APAC

South America

  • Brazil
  • Argentina
  • Rest of South America

Middle East and Africa (MEA)

  • GCC Countries
  • South Africa
  • Egypt
  • Rest of MEA

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Segment 1
      • By Segment 2
      • By Segment 3
    • Strategies of Key Players
    • Insight From the Horse’s Mouth
  • Company Profiles
    • QIAGEN
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis
    • BIOMÉRIEUX
    • Oxford Immunotec
    • SD Biosensor, INC.
    • Wantai BioPharm
    • Lionex GmbH

FAQ's

Answer : QFT-Plus (QuantiFERON-TB Gold Plus) holds 70% of the market. It is widely used due to its high sensitivity and ability to detect latent tuberculosis infections with a blood test, providing accurate results without the need for a skin test.

Answer : The Others category represents 30% of the market. This includes other TB testing brands and methods that are used, although QFT-Plus (QuantiFERON-TB Gold Plus) dominates the market.

Answer : The Tuberculin Skin Test (TST) captures 60% of the market. TST is a widely used method for TB screening, particularly for detecting latent tuberculosis infection, by injecting a substance into the skin and measuring the reaction.

Answer : IGRA accounts for 40% of the market. It is a blood test that helps detect latent tuberculosis infection and is preferred for certain populations due to its higher accuracy compared to the skin test.

Answer : PLHIV makes up 45% of the market. Individuals living with HIV are at higher risk for TB, so testing for TB is a critical part of their healthcare routine to prevent and treat co-infection.

Answer : Household Contacts with Pulmonary TB account for 35% of the market. Family members and close contacts of individuals with active pulmonary TB are prioritized for testing due to their higher risk of exposure.

Answer : The Others category holds 20% of the market. This includes various other populations or groups that require tuberculosis testing, though they represent a smaller portion compared to PLHIV and household contacts.

Answer : Diagnostic Laboratories account for 50% of the market. They are a central part of the testing process, offering TB diagnostic tests and providing accurate results through advanced testing equipment.

Answer : Hospitals and Clinics make up 35% of the market. They play a crucial role in TB diagnosis, especially in high-risk areas, offering testing services and treatment to patients with suspected TB.

Answer : Academic & Research Institutions hold 15% of the market. These institutions contribute to advancing TB testing methods and technologies, often involved in research and development to improve testing accuracy and detection.
Any Questions

Meet the Team

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.

Learn more about Shivani Zoting

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar